Effect of alprazolam and clonazepam on blood glucose in adult panic patients
Phase 2
- Conditions
- panic disorder.Panic disorder [episodic paroxysmal anxiety]
- Registration Number
- IRCT2016040722991N3
- Lead Sponsor
- Vice Chancellor for research of Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
age 18 years and over; filling out the informed consent form; psychiatric diagnosis of panic disorder; no desire to be pregnant during the study and to use proper contraceptive; no use of psychoactive drugs at least in one week before entering the study
Exclusion criteria: active suicidal thoughts; disorders in which it is contraindicated to use sertraline, alprazolam and clonazepam; past history or having psychotic or bipolar disorders; pregnancy or breast feeding; uncontrolled convulsion disorders; a personality disorder in severity which worsens the evaluation of efficacy and safety of treatment; co-treatment with other psychotropic drugs; diabetes mellitus
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose. Timepoint: 12th week. Method of measurement: blood test.;Two hours post-prandial blood glucose. Timepoint: 12th week. Method of measurement: blood test.;Hemoglubine A!C. Timepoint: 12th week. Method of measurement: blood test.
- Secondary Outcome Measures
Name Time Method The number of panic attacks. Timepoint: weekly. Method of measurement: psychiatric visit.